Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Zanubrutinib

4f98cd13-b210-5655-ba0f-4c7dd9a271f9 · FDA Approved · targets BTK

Zanubrutinib

MeasuredReference

Zanubrutinib targets ERBB4_HER4, BMX_ETK, BLK.

Primary targets

ERBB4_HER4BMX_ETKBLKBTKTXK

Top hallmarks

No hallmark data.

Top pathways disrupted

  • allograft rejection6.4k
  • apical junction6.1k
  • pi3k akt mtor signaling4.9k

Resistance landscape — Zanubrutinib

MeasuredReference

5 known oncogenic variants exist on Zanubrutinib's top targets — see detail for inhibition impact.

Open in new tab